Abnormal Pap Test Results: What They Mean and What Happens Next

Related service: Annual Well-Woman Exam

An abnormal Pap test does not mean that a patient has cervical cancer. It means that cervical cells showed a change that requires risk-based follow-up. The next step depends on the exact cytology result, high-risk HPV result, age, pregnancy status, immune status, prior screening history, and any previous precancer treatment. Some patients repeat HPV-based testing; others need colposcopy and biopsy. Timely follow-up is what prevents most cervical cancers.

Pap Testing and HPV Testing Answer Different Questions

A Pap test examines cervical cells for abnormalities. An HPV test looks for high-risk human papillomavirus types that can cause cervical precancer and cancer. Screening may use primary HPV testing, Pap testing alone, or cotesting depending on age, available testing, history, and current guidance.

HPV is extremely common and is transmitted through intimate skin-to-skin sexual contact. A positive HPV result does not identify when exposure occurred or from whom. The virus can become undetectable and later be detected again, so a new positive result does not prove recent infidelity. Most infections clear or become controlled without causing precancer.

Common Pap Test Results

ASC-US means atypical squamous cells of undetermined significance. These mild changes are common and may be related to HPV, inflammation, menopause-related tissue changes, or sampling variation. The high-risk HPV result and previous history usually determine whether repeat testing or colposcopy is recommended.

LSIL means low-grade squamous intraepithelial lesion and often reflects a transient HPV effect. HSIL indicates a higher probability of significant precancer and generally requires prompt colposcopic evaluation or, in selected nonpregnant patients, discussion of expedited treatment. ASC-H means high-grade disease cannot be excluded. AGC involves glandular cells and requires a broader evaluation because abnormalities can arise from the cervix or endometrium.

Why Follow-Up Is Based on Risk

Modern management uses the estimated risk of current or future cervical precancer rather than treating every result in isolation. A first HPV-positive low-grade result after reassuring prior HPV-based screening may be managed differently from the same result in a patient with persistent HPV, an overdue screening history, or prior cervical intraepithelial neoplasia.

This is why advice from a friend with a similar-sounding result may not apply. The laboratory wording, HPV genotype, previous tests, prior colposcopy or treatment, age, and immune status all change the recommendation. The safest plan comes from reviewing the complete screening record.

What Happens During Colposcopy

Colposcopy uses magnification and a bright light to examine the cervix after application of solutions that make abnormal areas easier to identify. A speculum is placed as with a Pap test. Small biopsies may be taken, and endocervical sampling may be performed when indicated. The colposcope remains outside the body.

Cramping and light bleeding or dark discharge can occur after biopsy. Patients receive instructions about intercourse, tampons, and warning signs. Fever, severe pain, foul discharge, or heavy bleeding should prompt a call. A normal-looking colposcopy does not always eliminate the need for surveillance because screening and biopsy history remain part of risk assessment.

Understanding Biopsy Results

CIN 1 is a low-grade change that often regresses and is commonly observed with follow-up rather than treated. CIN 2 and CIN 3 are high-grade precancers. Management depends on age, pregnancy plans, visibility of the lesion, endocervical findings, prior history, and the ability to follow closely.

Excisional treatment such as LEEP removes the transformation zone and provides tissue for pathology. Benefits include treating high-grade disease and excluding hidden invasion. Risks include bleeding, infection, cervical stenosis, and a small increase in future preterm birth risk, especially with deeper or repeated excisions. Treatment should be appropriately targeted, not automatic for every HPV infection.

Pregnancy and Abnormal Screening

Pregnancy changes the timing and type of management but does not eliminate the need for evaluation. Colposcopy and clinically indicated biopsy can be performed during pregnancy by an experienced clinician. Endocervical curettage is avoided. Treatment of precancer is generally deferred until after delivery unless invasive cancer is suspected.

Patients planning pregnancy should complete overdue follow-up when possible. A prior LEEP does not mean a future pregnancy will be preterm, but the obstetric team should know the cervical treatment history. The depth and number of excisions matter more than the label alone.

HPV Vaccination Still Matters

HPV vaccination prevents new infections with vaccine-covered types but does not treat an existing infection or abnormal Pap result. Vaccination is routinely recommended through age 26 and may be considered through age 45 using shared decision-making. Vaccinated patients still need recommended cervical screening because the vaccine does not cover every cancer-associated type and may have been given after prior exposure.

When Symptoms Need Evaluation Regardless of Screening

Screening is intended for people without symptoms. Bleeding after intercourse, persistent unexplained discharge, pelvic pain, or postmenopausal bleeding needs diagnostic evaluation even if the last Pap test was normal. A Pap test can miss disease and does not evaluate the uterus, ovaries, vulva, or most vaginal conditions.

Frequently Asked Questions

Does an abnormal Pap test mean cancer?

No. Most abnormal results reflect HPV-related or low-grade changes. The purpose of follow-up is to identify and treat precancer before it becomes cancer.

Can HPV appear years after exposure?

Yes. HPV can remain latent or below detection and later become detectable. A positive result cannot reliably date the exposure.

Will I need a LEEP?

Only if risk and biopsy findings support treatment. Many low-grade results are monitored, while high-grade precancer more often requires excision.

Can menopause cause an abnormal result?

Low-estrogen tissue changes can affect cytology and sampling, but HPV and precancer still must be considered. Repeat testing after local estrogen may be appropriate in selected patients.

How urgent is follow-up?

The recommended interval depends on the result. HSIL, ASC-H, AGC, or suspected cancer needs prompt evaluation, while some low-risk results are safely repeated at a defined interval.

Schedule Follow-Up

The Bottom Line

Abnormal Pap Test Results is best approached with individualized assessment rather than a one-size-fits-all plan. A visit can clarify what evaluation or treatment fits your symptoms, history, and goals.

Schedule a Visit

Complete Healthcare offers individualized follow-up after abnormal cervical screening, including colposcopy counseling for patients in Richland and the Tri-Cities. Call 509-392-6700 to schedule a colposcopy consultation.

Complete Healthcare, Richland, WA

Richard Lorenzo, D.O.

Women’s Health and Wellness Care in Richland, WA